Kirk D. Jones
University of California, San Francisco
ORCID: 0000-0002-0275-3503Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 12 papers. Top paper: “Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study”.
Anatoly Urisman, Matthew A. Gubens, Claire K. Mulvey, Greg M. Allen, Stephen Shiboski +19 more
Ying Wei, Genevieve Montas, Darren Leong, Jeffrey A. Golden, Binh N. Trinh +12 more
Young me Yoon, Sara E. Vazquez, Tania Estefania Velez, Kirk D. Jones, Cathryn T. Lee +12 more
Alexis N. Brumwell, Tsung Che Ho, Genevieve Montas, Jeffrey A. Golden, Kirk D. Jones +5 more
Young me Yoon, Sara E. Vazquez, Tania E. Velez, Kirk D. Jones, Cathryn T. Lee +12 more
Susie A. Lee, Everardo Macías, Ernest T. Lam, Chuanrui Xu, Kirk D. Jones +4 more
Susie A. Lee, Everardo Macías, Ernest T. Lam, Chuanrui Xu, Kirk D. Jones +4 more
Alexis N. Brumwell, Tsung Che Ho, Kiana Garakani, Genevieve Montas, Darren Leong +11 more
S.T. Virk, Haocheng Ding, Samuel S. Epstein, Kirk D. Jones, Omar Alneser +16 more
Katharine Clapham, Steven M. Kawut, Kirk D. Jones, John Ryan, Dolores Petty +18 more
Monica Fung, Steven R. Hays, Jonathan P. Singer, Mary Ellen Kleinhenz, Lorriana E. Leard +9 more
Christopher S. Law, Frances O. Ho, Kristin M. Wang, Kirk D. Jones, Jeoung‐Sook Shin +2 more